IBRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Immunitybio Inc and Microsoft Corporation in 2026
IBRX
Immunitybio Inc
$8.11
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | IBRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $7.88B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | IBRX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 425.1% | 18.4% | IBRX |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze IBRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBRX or MSFT a better investment?
Comparing IBRX and MSFT: Immunitybio Inc has a market cap of $7.88B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBRX and MSFT?
IBRX (Immunitybio Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBRX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBRX or MSFT?
IBRX has higher revenue growth at 425.1% vs 18.4% for MSFT.
Which company is more profitable: IBRX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for IBRX.
Which is the larger company: IBRX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $7.88B for IBRX.
Should I buy IBRX or MSFT in 2026?
Both IBRX and MSFT have investment merit. IBRX trades at $8.11 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBRX and MSFT stock?
Key differences: Market Cap ($7.88B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (425.1% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy IBRX or MSFT in 2026?
The choice between IBRX and MSFT depends on your investment goals. IBRX shows higher revenue growth (425.1%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between IBRX and MSFT?
IBRX (Immunitybio Inc) has a market cap of $7.88B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.